Eli Lilly (LLY) FY2024 results: revenue $45.0 billion, up 32.0% on the year
Eli Lilly & Co. (LLY) reported revenue of $45.0 billion for fiscal 2024, the year ended 31 December 2024, up 32.0% on the year before. Net income was $10.6 billion, up 102.1%, and diluted earnings per share $11.71. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2025.
Revenue
$45.0 billion
+32.0% on the year
FY2017FY2024
Operating margin
n/a
FY2017FY2024
Net income
$10.6 billion
+102.1% on the year
FY2017FY2024
Diluted EPS
$11.71
+101.9% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
8,818
4,240
7,586
+108.0%
Capital expenditure
5,058
3,448
1,854
+46.7%
Free cash flow
3,760
792
5,731
+374.5%
Free cash flow margin
8.3%
2.3%
20.1%
Cash from investing
-9,302
-7,153
-3,763
Cash from financing
1,230
3,496
-5,407
-64.8%
Depreciation and amortisation
1,767
1,527
1,522
+15.7%
Share-based compensation
646
628
371
+2.7%
Buybacks
2,500
750
1,500
+233.3%
Dividends paid
4,680
4,069
3,536
+15.0%
Dividend per share
$5.40
$4.69
$4.07
+15.1%
Diluted shares, weighted
904m
903m
905m
+0.1%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
14,272
10,772
10,650
+32.5%
Non-controlling interest
79.5
91.8
126
-13.4%
Debt
33,644
25,225
16,239
+33.4%
Operating lease liabilities
971
948
n/a
+2.4%
Other liabilities
29,748
26,969
22,476
+10.3%
Total liabilities and equity
78,715
64,006
49,490
+23.0%
Fixed assets
17,102
12,914
10,144
+32.4%
Goodwill
5,770
4,940
4,073
+16.8%
Intangible assets
6,166
6,907
7,207
-10.7%
Investments
3,371
3,161
3,047
+6.6%
Cash and equivalents
3,268
2,819
2,067
+16.0%
Receivables
11,006
9,090
6,896
+21.1%
Inventory
7,589
5,773
4,310
+31.5%
Other assets
24,442
18,403
11,747
+32.8%
Total assets
78,715
64,006
49,490
+23.0%
10-K for the year ended 31 December 2024, filed 19 February 2025: the filing.